Beta-Globin Quantitative Test Cost AED: 1020.0
Test Name: Beta-Globin Quantitative Test
Components: Whole Blood, Culture Cells
Price: 1020.0 AED
Sample Condition: Whole Blood, Culture Cells
Report Delivery: 3rd Working Day Email: 36 hours. On phone: 24 hours
Method: Real Time PCR
Test Type: Viral
Doctor: Physician
Test Department: Genetics
Pre Test Information: Need to sign Consent document and bring any clinical history of patient for Beta-Globin Quantitative Test
Test Details
The Beta-Globin Quantitative Test is a laboratory test used to measure the amount of beta-globin in a person’s blood. Beta-globin is a component of hemoglobin, the protein responsible for carrying oxygen in red blood cells.
This test is typically ordered to evaluate and monitor certain blood disorders, such as thalassemia and sickle cell disease. These conditions are characterized by abnormal or reduced production of beta-globin, which can lead to anemia and other complications.
During the test, a blood sample is taken from the patient and analyzed in a laboratory. The test measures the level of beta-globin in the blood, which can help determine the severity of the blood disorder and guide treatment decisions.
The results of the Beta-Globin Quantitative Test are reported as a percentage or ratio, indicating the amount of beta-globin present compared to normal levels. Higher percentages or ratios indicate a higher level of beta-globin, while lower percentages or ratios indicate a lower level.
It is important to note that the Beta-Globin Quantitative Test is different from the Beta-Globin Gene Mutation Test, which is used to identify specific genetic mutations that can cause blood disorders. The quantitative test measures the amount of beta-globin, while the gene mutation test identifies specific genetic abnormalities.
Overall, the Beta-Globin Quantitative Test is a useful tool in evaluating and managing blood disorders that affect beta-globin production. It provides valuable information to healthcare providers in order to guide treatment decisions and monitor the progress of the condition.
Test Name | Beta-Globin Quantitative Test |
---|---|
Components | |
Price | 1020.0 AED |
Sample Condition | Whole Blood, Culture Cells |
Report Delivery | 3rd Working Day Email:-36 hours. On phone: 24 hours |
Method | Real Time PCR |
Test type | Viral |
Doctor | Physician |
Test Department: | Genetics |
Pre Test Information | Need to sign Consent document and bring any clinical history of patient forBeta-Globin QuantitativeTest |
Test Details |
The Beta-Globin Quantitative Test is a laboratory test used to measure the amount of beta-globin in a person’s blood. Beta-globin is a component of hemoglobin, the protein responsible for carrying oxygen in red blood cells. This test is typically ordered to evaluate and monitor certain blood disorders, such as thalassemia and sickle cell disease. These conditions are characterized by abnormal or reduced production of beta-globin, which can lead to anemia and other complications. During the test, a blood sample is taken from the patient and analyzed in a laboratory. The test measures the level of beta-globin in the blood, which can help determine the severity of the blood disorder and guide treatment decisions. The results of the Beta-Globin Quantitative Test are reported as a percentage or ratio, indicating the amount of beta-globin present compared to normal levels. Higher percentages or ratios indicate a higher level of beta-globin, while lower percentages or ratios indicate a lower level. It is important to note that the Beta-Globin Quantitative Test is different from the Beta-Globin Gene Mutation Test, which is used to identify specific genetic mutations that can cause blood disorders. The quantitative test measures the amount of beta-globin, while the gene mutation test identifies specific genetic abnormalities. Overall, the Beta-Globin Quantitative Test is a useful tool in evaluating and managing blood disorders that affect beta-globin production. It provides valuable information to healthcare providers in order to guide treatment decisions and monitor the progress of the condition. |